Clinical Trials
3 trialsNCT03112603 2025-08-12
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Incyte Corporation
Phase 3 Completed
NCT06075810 2024-12-12
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
MBQ Pharma
Phase 1 Recruiting
NCT02957266 2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3 Unknown